Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 2476824, 9 pages
https://doi.org/10.1155/2018/2476824
Review Article

Alternative and Natural Therapies for Acute Lung Injury and Acute Respiratory Distress Syndrome

1Division of Pulmonology, Norton Thoracic Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, USA
2Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Florida, Gainesville, FL, USA
3Division of Applied Medicine, School of Korean Medicine, Pusan National University, Yangsan 626-870, Republic of Korea
4Department of Veterans Affairs, Atlanta VAMC, Emory University School of Medicine, Atlanta, GA, USA
5Division of Pulmonary and Critical Care Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA

Correspondence should be addressed to Vipul J. Patel; moc.liamg@demlupiv

Received 20 July 2017; Accepted 8 April 2018; Published 16 May 2018

Academic Editor: Joanna Domagala-Kulawik

Copyright © 2018 Vipul J. Patel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. R. Johnson and M. A. Matthay, “Acute lung injury: epidemiology, pathogenesis, and treatment,” Journal of Aerosol Medicine and Pulmonary Drug Delivery, vol. 23, no. 4, pp. 243–252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Mason, N. Dooley, and M. Griffiths, “Acute respiratory distress syndrome,” Clinical Medicine, vol. 16, no. Suppl_6, pp. s66–s70, 2016. View at Publisher · View at Google Scholar
  3. J. Villar and A. S. Slutsky, “GOLDEN anniversary of the acute respiratory distress syndrome: still much work to do!,” Current Opinion in Critical Care, vol. 23, no. 1, pp. 4–9, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. V. M. Ranieri, G. D. Rubenfeld, B. T. Thompson et al., “Acute respiratory distress syndrome: the Berlin definition,” The Journal of the American Medical Association, vol. 307, no. 23, pp. 2526–2533, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. J. Sweatt and J. E. Levitt, “Evolving epidemiology and definitions of the acute respiratory distress syndrome and early acute lung injury,” Clinics in Chest Medicine, vol. 35, no. 4, pp. 609–624, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Pham and G. D. Rubenfeld, “Fifty years of research in ards the epidemiology of acute respiratory distress syndrome a 50th birthday review,” American Journal of Respiratory and Critical Care Medicine, vol. 195, no. 7, pp. 860–870, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Butt, A. Kurdowska, and T. C. Allen, “Acute Lung Injury: A Clinical and Molecular Review,” Archives of pathology & laboratory medicine, vol. 140, no. 4, pp. 345–350, 2016. View at Publisher · View at Google Scholar
  8. M. Confalonieri, F. Salton, and F. Fabiano, “Acute respiratory distress syndrome,” European Respiratory Review, vol. 26, no. 144, Article ID 160116, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Fanelli, A. Vlachou, S. Ghannadian et al., “Acute respiratory distress syndrome: new definition, current and future therapeutic options,” Journal of Thoracic Disease, vol. 5, no. 3, pp. 326–334, 2013. View at Google Scholar
  10. L. B. Ware, “Pathophysiology of acute lung injury and the acute respiratory distress syndrome,” Seminars in Respiratory and Critical Care Medicine, vol. 27, no. 4, pp. 337–349, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. K. S. Farley, L. F. Wang, H. M. Razavi et al., “Effects of macrophage inducible nitric oxide synthase in murine septic lung injury,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 290, no. 6, pp. L1164–L1172, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. W. R. Henderson, L. Chen, M. B. Amato, and L. J. Brochard, “Fifty Years of Research in ARDS. Respiratory Mechanics in Acute Respiratory Distress Syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 196, no. 7, pp. 822–833, 2017. View at Publisher · View at Google Scholar
  13. J. W. Cannon, J. T. Gutsche, and D. Brodie, “Optimal Strategies for Severe Acute Respiratory Distress Syndrome,” Critical Care Clinics, vol. 33, no. 2, pp. 259–275, 2017. View at Publisher · View at Google Scholar
  14. J. G. Laffey and B. P. Kavanagh, “Fifty Years of Research in ARDS. Insight into ARDS - From Models to Patients. American journal of respiratory and critical care medicine,” American Journal of Respiratory and Critical Care Medicine, vol. 196, no. 1, pp. 18–28, 2017. View at Publisher · View at Google Scholar
  15. S. Han and R. K. Mallampalli, “The acute respiratory distress syndrome: from mechanism to translation,” The Journal of Immunology, vol. 194, no. 3, pp. 855–860, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. A. J. Boyle, R. M. Sweeney, and D. F. McAuley, “Pharmacological treatments in ARDS; a state-of-the-art update,” BMC Medicine, vol. 11, no. 1, 2013. View at Publisher · View at Google Scholar
  17. D. Impellizzeri, G. Bruschetta, E. Esposito, and S. Cuzzocrea, “Emerging drugs for acute lung injury,” Expert Opinion on Emerging Drugs, vol. 20, no. 1, pp. 75–89, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. M. S. Hayden, A. P. West, and S. Ghosh, “NF-κB and the immune response,” Oncogene, vol. 25, no. 51, pp. 6758–6780, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Yuan, MA. Syed, D. Panchal et al., “Curcumin mediated epigenetic modulation inhibits TREM-1 expression in response to lipopolysaccharide [Research Support, U.S. Gov't, Non-P.H.S.],” The international journal of biochemistry & cell biology, vol. 44, no. 11, pp. 2032–2043, 2012. View at Publisher · View at Google Scholar
  20. Y. X. Xu, K. R. Pindolia, N. Janakiraman et al., “Curcumin inhibits IL1 alpha and TNF- alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells [Research Support, Non-U.S. Gov't],” Hematopathology and molecular hematology, vol. 11, no. 1, pp. 49–62, 1997. View at Google Scholar
  21. T. Kim, E. Joh, B. Kim, and D. Kim, “Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor-4 on macrophages,” International Immunopharmacology, vol. 12, no. 1, pp. 110–116, 2012. View at Publisher · View at Google Scholar
  22. M. Huo, N. Chen, G. Chi et al., “Traditional medicine alpinetin inhibits the inflammatory response in Raw 264.7 cells and mouse models [Research Support, Non-U.S. Gov't],” International immunopharmacology, vol. 12, no. 1, pp. 241–248, 2012. View at Google Scholar
  23. M. Wei, X. Chu, L. Jiang et al., “Protocatechuic acid attenuates lipopolysaccharide-induced acute lung injury,” Inflammation, vol. 35, no. 3, pp. 1169–1178, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Chu, X. Ci, M. Wei et al., “Licochalcone A inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo,” Journal of Agricultural and Food Chemistry, vol. 60, no. 15, pp. 3947–3954, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Chu, X. Ci, J. He et al., “Effects of a Natural Prolyl Oligopeptidase Inhibitor, Rosmarinic Acid, on Lipopolysaccharide-Induced Acute Lung Injury in Mice,” Molecules, vol. 17, no. 3, pp. 3586–3598, 2012. View at Publisher · View at Google Scholar
  26. C.-Y. Sun, C.-Q. Pei, B.-X. Zang, L. Wang, and M. Jin, “The ability of hydroxysafflor yellow a to attenuate lipopolysaccharide-induced pulmonary inflammatory injury in mice,” Phytotherapy Research, vol. 24, no. 12, pp. 1788–1795, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Wu, L. Wang, M. Jin et al., “Hydroxysafflor yellow A alleviates early inflammatory response of bleomycin-induced mice lung injury [Research Support Non-U.S. Gov't],” Biological & pharmaceutical bulletin, vol. 35, no. 4, Article ID 22466555, pp. 515–522, 2012. View at Google Scholar
  28. M. Huo, X. Cui, J. Xue et al., “Anti-inflammatory effects of linalool in RAW 264.7 macrophages and lipopolysaccharide-induced lung injury model,” Journal of Surgical Research, vol. 180, no. 1, pp. e47–e54, 2013. View at Publisher · View at Google Scholar
  29. J.-L. Yu, X.-S. Zhang, X. Xue, and R.-M. Wang, “Patchouli alcohol protects against lipopolysaccharide-induced acute lung injury in mice,” Journal of Surgical Research, 2014. View at Publisher · View at Google Scholar
  30. G. Z. Bai, H. T. Yu, Y. F. Ni et al., “Shikonin attenuates lipopolysaccharide-induced acute lung injury in mice,” Journal of Surgical Research, vol. 182, no. 2, pp. 303–311, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. T. I. Weng, H. Y. Wu, C. W. Kuo, and S. H. Liu, “Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation,” Intensive Care Medicine, vol. 37, no. 3, pp. 533–541, 2011. View at Publisher · View at Google Scholar
  32. W. Yang, D. Qiang, M. Zhang et al., “Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models,” International Immunopharmacology, vol. 11, no. 6, pp. 683–692, 2011. View at Publisher · View at Google Scholar
  33. V. Patel, N. Grinkina, D. Butnariu et al., “Therapeutic use of sophorolipids in attenuation of vascular leak in murine lung injury model,” in American journal of respiratory and critical care medicine, p. A238, SUNY Downstate Medical Center, Brooklyn, NY, USA, 2007. View at Google Scholar
  34. O. Koksel, A. Ozdulger, L. Tamer et al., “Effects of caffeic acid phenethyl ester on lipopolysaccharide-induced lung injury in rats,” Pulmonary pharmacology & therapeutics, vol. 19, no. 2, pp. 90–95, 2006. View at Publisher · View at Google Scholar
  35. Q. Sun, L. Chen, M. Gao et al., “Ruscogenin inhibits lipopolysaccharide-induced acute lung injury in mice: Involvement of tissue factor, inducible NO synthase and nuclear factor (NF)-κB,” International Immunopharmacology, vol. 12, no. 1, pp. 88–93, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. R. D. Novaes, R. V. Gonçalves, M. C. Cupertino et al., “Bark extract of Bathysa cuspidata attenuates extra-pulmonary acute lung injury induced by paraquat and reduces mortality in rats,” International Journal of Clinical and Experimental Pathology, vol. 93, no. 3, pp. 225–233, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Shin, I. Shin, H. Song et al., “Callicarpa japonica Thunb. reduces inflammatory responses: A mouse model of lipopolysaccharide-induced acute lung injury,” International Immunopharmacology, vol. 26, no. 1, pp. 174–180, 2015. View at Publisher · View at Google Scholar
  38. N. Chainani-Wu, “Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa),” The Journal of Alternative and Complementary Medicine, vol. 9, no. 1, pp. 161–168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Jacob, R. Wu, M. Zhou, and P. Wang, “Mechanism of the anti-inflammatory effect of curcumin: PPAR-γ activation,” PPAR Research, vol. 2007, Article ID 89369, 5 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. J. H. Lyu, K. H. Kim, H. W. Kim et al., “Dangkwisoo-san, an herbal medicinal formula, ameliorates acute lung inflammation via activation of Nrf2 and suppression of NF-κB,” Journal of Ethnopharmacology, vol. 140, no. 1, pp. 107–116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. J. H. Lyu, G. S. Lee, K. H. Kim et al., “ent-kaur-16-en-19-oic acid, isolated from the roots of Aralia continentalis, induces activation of Nrf2,” Journal of Ethnopharmacology, vol. 137, no. 3, pp. 1442–1449, 2011. View at Publisher · View at Google Scholar
  42. J.-Y. Choi, M. J. Kwun, K. H. Kim et al., “Protective effect of the fruit hull of Gleditsia sinensis on LPS-induced acute lung injury is associated with Nrf2 activation,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 974713, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Kim, J. Woo, J. H. Lyu et al., “Carthami Flos suppresses neutrophilic lung inflammation in mice, for which nuclear factor-erythroid 2-related factor-1 is required,” Phytomedicine, vol. 21, no. 4, pp. 470–478, 2014. View at Publisher · View at Google Scholar
  44. C.-Y. Ho, Y.-T. Cheng, C.-F. Chau, and G.-C. Yen, “Effect of diallyl sulfide on in vitro and in vivo Nrf2-mediated pulmonic antioxidant enzyme expression via activation ERK/p38 signaling pathway,” Journal of Agricultural and Food Chemistry, vol. 60, no. 1, pp. 100–107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. C.-L. Tsai, Y.-C. Lin, H.-M. Wang, and T.-C. Chou, “Baicalein, an active component of Scutellaria baicalensis, protects against lipopolysaccharide-induced acute lung injury in rats,” Journal of Ethnopharmacology, vol. 153, no. 1, pp. 197–206, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Park, B. T. Jeon, H. C. Kim et al., “Aged red garlic extract reduces lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophages and acute pulmonary inflammation through haeme oxygenase-1 induction,” Acta Physiologica, vol. 205, no. 1, pp. 61–70, 2012. View at Publisher · View at Google Scholar
  47. M. A. Syed, M. Joo, Z. Abbas et al., “Expression of TREM-1 is inhibited by PGD2 and PGJ2 in macrophages,” Experimental Cell Research, vol. 316, no. 19, pp. 3140–3149, 2010. View at Publisher · View at Google Scholar
  48. Z. Yuan, M. A. Syed, D. Panchal et al., “Triggering receptor expressed on myeloid cells 1 (TREM-1)-mediated Bcl-2 induction prolongs macrophage survival,” The Journal of Biological Chemistry, vol. 289, no. 21, pp. 15118–15129, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. H. Wu, S. Y. Chuang, W. C. Hong, Y. J. Lai, Y. L. Chang, and J. H. S. Pang, “In vivo and in vitro inhibitory effects of a traditional Chinese formulation on LPS-stimulated leukocyte-endothelial cell adhesion and VCAM-1 gene expression,” Journal of Ethnopharmacology, vol. 140, no. 1, pp. 55–63, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. E. S. Kang, I. S. Woo, H. J. Kim et al., “Up-regulation of aldose reductase expression mediated by phosphatidylinositol 3-kinase/Akt and Nrf2 is involved in the protective effect of curcumin against oxidative damage [Research Support, Non-U.S. Gov't],” Free radical biology & medicine, vol. 43, no. 4, pp. 535–545, 2007. View at Publisher · View at Google Scholar
  51. H. J. Mehta, V. Patel, and R. T. Sadikot, “Curcumin and lung cancer—a review,” Targeted Oncology, vol. 9, no. 4, pp. 295–310, 2014. View at Publisher · View at Google Scholar
  52. E. Balogun, R. Foresti, C. J. Green, and R. Motterlini, “Changes in temperature modulate heme oxygenase-1 induction by curcumin in renal epithelial cells,” Biochemical and Biophysical Research Communications, vol. 308, no. 4, pp. 950–955, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Kesecioglu, R. Beale, T. E. Stewart et al., “Exogenous Natural Surfactant for Treatment of Acute Lung Injury and the Acute Respiratory Distress Syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 10, pp. 989–994, 2009. View at Publisher · View at Google Scholar
  54. R. T. Sadikot, “Peptide Nanomedicines for Treatment of Acute Lung Injury,” in Nanomedicine - Cancer, Diabetes, and Cardiovascular, Central Nervous System, Pulmonary and Inflammatory Diseases, vol. 508 of Methods in Enzymology, pp. 315–324, Elsevier, 2012. View at Publisher · View at Google Scholar
  55. R. T. Sadikot, “The potential role of nano- and micro-technology in the management of critical illnesses,” Advanced Drug Delivery Reviews, vol. 77, pp. 27–31, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. R. T. Sadikot and I. Rubinstein, “Long-acting, multi-targeted nanomedicine: Addressing unmet medical need in acute lung injury,” Journal of Biomedical Nanotechnology, vol. 5, no. 6, pp. 614–619, 2009. View at Publisher · View at Google Scholar · View at Scopus